KLAC vs. ASND
KLAC (KLA Corporation) and ASND (Ascendis Pharma A/S) are both stocks. KLAC operates in Semiconductor Equipment & Materials (Technology), while ASND operates in Biotechnology (Healthcare). Over the past 10 years, KLAC returned 45.08%/yr vs 33.14%/yr for ASND. At a 0.20 correlation, their price movements are largely independent.
Performance
KLAC vs. ASND - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KLAC achieves a 110.02% return, which is significantly higher than ASND's 2.26% return. Over the past 10 years, KLAC has outperformed ASND with an annualized return of 45.08%, while ASND has yielded a comparatively lower 33.14% annualized return.
KLAC
- 1D
- 5.55%
- 1M
- 37.79%
- YTD
- 110.02%
- 6M
- 113.75%
- 1Y
- 192.78%
- 3Y*
- 75.88%
- 5Y*
- 52.93%
- 10Y*
- 45.08%
ASND
- 1D
- 1.14%
- 1M
- -10.48%
- YTD
- 2.26%
- 6M
- -1.07%
- 1Y
- 27.58%
- 3Y*
- 32.88%
- 5Y*
- 10.86%
- 10Y*
- 33.14%
KLAC vs. ASND - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KLAC KLA Corporation | 110.02% | 94.48% | 9.36% | 56.05% | -11.20% | 68.05% | 47.94% | 103.99% | -12.49% | 36.80% |
ASND Ascendis Pharma A/S | 2.26% | 54.89% | 9.31% | 3.13% | -9.22% | -19.34% | 19.88% | 122.06% | 56.39% | 97.92% |
Correlation
The correlation between KLAC and ASND is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jan 28, 2015 | 0.20 |
The correlation between KLAC and ASND shifts across timeframes, from -0.01 (1 year) to 0.20 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
KLAC:
$33.62B
ASND:
$14.07B
KLAC:
$35.29
ASND:
€8.08
KLAC:
7.21
ASND:
23.32
KLAC:
0.27
ASND:
0.11
KLAC:
2.57
ASND:
13.62
KLAC:
5.77
ASND:
24.89
KLAC:
$13.10B
ASND:
€867.51M
KLAC:
$8.09B
ASND:
€764.89M
KLAC:
$5.77B
ASND:
-€6.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KLAC vs. ASND — Risk / Return Rank
KLAC
ASND
KLAC vs. ASND - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KLA Corporation (KLAC) and Ascendis Pharma A/S (ASND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KLAC | ASND | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.18 | ||
| Sortino ratioReturn per unit of downside risk | +2.46 | ||
| Omega ratioGain probability vs. loss probability | 1.54 | 1.15 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | 8.66 | 1.59 | +7.07 |
| Martin ratioReturn relative to average drawdown | 27.54 | 4.87 | +22.67 |
Loading charts...
Drawdowns
KLAC vs. ASND - Drawdown Comparison
The maximum KLAC drawdown since its inception was -83.74%, which is greater than ASND's maximum drawdown of -61.72%. Use the drawdown chart below to compare losses from any high point for KLAC and ASND.
Loading charts...
Drawdown Indicators
| KLAC | ASND | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.74% | -61.72% | -22.02% |
Max Drawdown (1Y)Largest decline over 1 year | -22.41% | -17.62% | -4.79% |
Max Drawdown (3Y)Largest decline over 3 years | -34.95% | -29.15% | -5.80% |
Max Drawdown (5Y)Largest decline over 5 years | -40.28% | -60.46% | +20.18% |
Max Drawdown (10Y)Largest decline over 10 years | -40.28% | -61.72% | +21.44% |
Current DrawdownCurrent decline from peak | 0.00% | -12.72% | +12.72% |
Average DrawdownAverage peak-to-trough decline | -29.32% | -18.90% | -10.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.03% | 5.72% | +1.31% |
Volatility
KLAC vs. ASND - Volatility Comparison
KLA Corporation (KLAC) has a higher volatility of 22.17% compared to Ascendis Pharma A/S (ASND) at 13.12%. This indicates that KLAC's price experiences larger fluctuations and is considered to be riskier than ASND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KLAC | ASND | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.17% | 13.12% | +9.05% |
Volatility (6M)Calculated over the trailing 6-month period | 42.02% | 29.45% | +12.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.38% | 37.26% | +12.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.88% | 48.65% | -4.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.86% | 51.09% | -9.23% |
Dividends
KLAC vs. ASND - Dividend Comparison
KLAC's dividend yield for the trailing twelve months is around 0.31%, while ASND has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KLAC KLA Corporation | 0.31% | 0.61% | 0.96% | 0.92% | 1.25% | 0.91% | 1.35% | 1.74% | 3.17% | 2.15% | 2.67% | 2.94% |
Financials
KLAC vs. ASND - Financials Comparison
This section allows you to compare key financial metrics between KLA Corporation and Ascendis Pharma A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KLAC and ASND have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KLAC has higher volatility (22.17%) compared to ASND (13.12%). In terms of maximum drawdown, KLAC dropped -83.74% vs ASND's -61.72%.
KLAC currently has the higher Sharpe Ratio (3.93 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KLAC and ASND
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer